Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR Pathway

References

• Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;m3773. doi:10.1136/bmj.m3773
   PubMed Web of Science ®Google Scholar
• Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280–304. doi:10.3322/caac.21559
   PubMed Web of Science ®Google Scholar
• Ledermann JA. Front-line therapy of advanced ovarian cancer: new approaches. Ann Oncol. 2017;28:viii46–viii50. doi:10.1093/annonc/mdx452
   PubMed Web of Science ®Google Scholar
• Mirza MR, Coleman RL, González-Martín A, et al. The forefront of ovarian cancer therapy: update on PARP inhibitors. Ann Oncol. 2020;31(9):1148–1159. doi:10.1016/j.annonc.2020.06.004
   PubMed Web of Science ®Google Scholar
• Kurnit KC, Avila M, Hinchcliff EM, Coleman RL, Westin SN. PARP inhibition in the ovarian cancer patient: current approvals and future directions. Pharmacol Ther. 2020;213:107588. doi:10.1016/j.pharmthera.2020.107588
   PubMed Web of Science ®Google Scholar
• Correia-da-silva M, Sousa E, Pinto MMM, Kijjoa A. Anticancer and cancer preventive compounds from edible marine organisms. Semin Cancer Biol. 2017;46:55–64. doi:10.1016/j.semcancer.2017.03.011
   PubMed Web of Science ®Google Scholar
• Pangestuti R, Arifin Z. Medicinal and health benefit effects of functional sea cucumbers. J Tradit Complement Med. 2018;8(3):341–351. doi:10.1016/j.jtcme.2017.06.007
   PubMedGoogle Scholar
• Aminin DL, Menchinskaya ES, Pisliagin E, et al. Anticancer activity of sea cucumber triterpene glycosides. Mar Drugs. 2015;13(3):1202–1223. doi:10.3390/md13031202
   PubMed Web of Science ®Google Scholar
• Dong J, Liang W, Wang T, et al. Saponins regulate intestinal inflammation in colon cancer and IBD. Pharmacol Res. 2019;144:66–72. doi:10.1016/j.phrs.2019.04.010
   PubMed Web of Science ®Google Scholar
• Shimada S. Antifungal steroid glycoside from sea cucumber. Science. 1969;163(3874):1462. doi:10.1126/science.163.3874.1462
   PubMed Web of Science ®Google Scholar
• Wargasetia TL, Permana S, Widodo N. Potential use of compounds from sea cucumbers as MDM2 and CXCR4 inhibitors to control cancer cell growth. Exp Ther Med. 2018. doi:10.3892/etm.2018.6588
   PubMed Web of Science ®Google Scholar
• Yoshida S, Shimada Y, Kondoh D, et al. Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs malaria parasite development. PLoS Pathog. 2007;3(12):e192. doi:10.1371/journal.ppat.0030192
   PubMed Web of Science ®Google Scholar
• Yun S-H, Park E-S, Shin S-W, et al. Stichoposide C induces apoptosis through the generation of ceramide in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res. 2012;18(21):5934–5948. doi:10.1158/1078-0432.Ccr-12-0655
   PubMed Web of Science ®Google Scholar
• Granville CA, Memmott RM, Gills JJ, Dennis PA. Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway. Clin Cancer Res. 2006;12(3):679–689. doi:10.1158/1078-0432.Ccr-05-1654
   PubMed Web of Science ®Google Scholar
• Han W, Yu F, Cao J, et al. Valproic acid enhanced apoptosis by promoting autophagy via Akt/mTOR signaling in glioma. Cell Transplant. 2020;29:096368972098187. doi:10.1177/0963689720981878
   Web of Science ®Google Scholar
• Hong P, Liu Q-W, Xie Y, et al. Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis. Cell Death Dis. 2020;11(7). doi:10.1038/s41419-020-2730-7
   Web of Science ®Google Scholar
• LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat. 2008;11(1–2):32–50. doi:10.1016/j.drup.2007.11.003
   PubMed Web of Science ®Google Scholar
• Papadimitrakopoulou V, Adjei AA. The Akt/mTOR and mitogen-activated protein kinase pathways in lung cancer therapy.. J Thorac Oncol. 2006;1(7):749–751.
   PubMed Web of Science ®Google Scholar
• Gao L, Wang Z, Lu D, et al. Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells. Cell Death Dis. 2019;10(8). doi:10.1038/s41419-019-1849-x
   Web of Science ®Google Scholar
• Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 2019;59:147–160. doi:10.1016/j.semcancer.2019.05.012
   PubMed Web of Science ®Google Scholar
• Popolo A, Pinto A, Daglia M, et al. Two likely targets for the anti-cancer effect of indole derivatives from cruciferous vegetables: PI3K/Akt/mTOR signalling pathway and the aryl hydrocarbon receptor. Semin Cancer Biol. 2017;46:132–137. doi:10.1016/j.semcancer.2017.06.002
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol. 2011;8(9):528–539. doi:10.1038/nrclinonc.2011.71
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Longo DL. Autophagy in human diseases. N Engl J Med. 2020;383(16):1564–1576. doi:10.1056/NEJMra2022774
   PubMed Web of Science ®Google Scholar
• Kopper O, de Witte CJ, Lõhmussaar K, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 2019;25(5):838–849. doi:10.1038/s41591-019-0422-6
   PubMed Web of Science ®Google Scholar
• Gourley C, Balmaña J, Ledermann JA, et al. Moving from poly (ADP-ribose) polymerase inhibition to targeting DNA repair and DNA damage response in cancer therapy. J Clin Oncol. 2019;37(25):2257–2269. doi:10.1200/jco.18.02050
   PubMed Web of Science ®Google Scholar
• Mathew R, White E. Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev. 2011;21(1):113–119. doi:10.1016/j.gde.2010.12.008
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18(1):1–24. doi:10.1186/s12943-018-0935-5
   PubMed Web of Science ®Google Scholar
• Driehuis E, Kretzschmar K, Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 2020;15(10):3380–3409. doi:10.1038/s41596-020-0379-4
   PubMed Web of Science ®Google Scholar
• Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol. 2005. doi:10.1200/jco.2005.01.5594
   Web of Science ®Google Scholar
• Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14(1). doi:10.1186/s12943-015-0321-5
   Web of Science ®Google Scholar
• Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008. doi:10.1007/978-1-59745-157-4_4
   PubMedGoogle Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012. doi:10.4161/auto.19496
   Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011;27(1):107–132. doi:10.1146/annurev-cellbio-092910-154005
   PubMed Web of Science ®Google Scholar
• Tang C, Yang L, Jiang X, et al. Antibiotic drug tigecycline inhibited cell proliferation and induced autophagy in gastric cancer cells. Biochem Biophys Res Commun. 2014;446(1):105–112. doi:10.1016/j.bbrc.2014.02.043
   PubMed Web of Science ®Google Scholar
• Kim KY, Park KI, Kim SH, et al. Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells. Int J Mol Sci. 2017;18(5):1088. doi:10.3390/ijms18051088
   PubMed Web of Science ®Google Scholar
• Wang K, Liu R, Li J, et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy. 2011;7(9):966–978. doi:10.4161/auto.7.9.15863
   PubMed Web of Science ®Google Scholar
• Xu Z, Han X, Ou D, et al. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020. doi:10.1007/s00253-019-10257-8
   Web of Science ®Google Scholar
• Balakrishnan K, Peluso M, Fu M, et al. The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL. Leukemia. 2015;29(9):1811–1822. doi:10.1038/leu.2015.105
   PubMed Web of Science ®Google Scholar
• Rong L, Li Z, Leng X, et al. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway. Biomed Pharmacother. 2020;122:109726. doi:10.1016/j.biopha.2019.109726
   PubMed Web of Science ®Google Scholar
• Fan X-J, Wang Y, Wang L, Zhu M. Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol Rep. 2016;36(6):3559–3567. doi:10.3892/or.2016.5138
   PubMed Web of Science ®Google Scholar